查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1789954

照護現場診斷脂質檢測市場規模、佔有率和趨勢分析報告：按產品、應用、疾病指徵、最終用途、地區和細分市場預測，2025 年至 2033 年

Point Of Care Lipid Test Market Size, Share & Trends Analysis Report By Product, By Application, By Disease Indication, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 136 Pages | 商品交期: 2-10個工作天內

價格

照護現場脂質檢測市場摘要

2024 年全球照護現場脂質檢測市場價值估計為 7.333 億美元，預計到 2033 年將達到 12.6833 億美元，2025 年至 2033 年的複合年成長率為 6.05%。市場成長的動力來自於臨床和臨床前環境中對快速、便捷的脂質分析日益成長的需求，特別是對於心血管疾病的早期檢測和監測。

照護現場脂質檢測提供了便利性、縮短了的周轉時間並提供了即時的臨床決策支持，有助於其在初級保健中心、藥房和社區健康計劃中的應用。

市場發展勢頭強勁，這得益於血脂異常症和文明病的日益流行以及人們對心血管風險管理意識的不斷提高。這些測試與數位健康平台和行動診斷的結合，進一步實現了分散式篩檢和預防性醫療保健的提供，特別是在醫療服務不足和農村地區。

照護現場血脂檢測 (POC) 使醫護人員能夠直接在患者所在地測量膽固醇及相關血脂水平，無需將檢體送至實驗室。這些檢測使用少量血液樣本（通常透過指尖採血），並透過攜帶式設備快速提供結果，幫助醫生更快地做出治療決策，尤其是在控制膽固醇問題和降低心臟病風險方面。

即時血脂檢測 (POC) 常用於常規篩檢、慢性病管理和急診護理。它們在實驗室條件有限的偏遠地區尤其有用。技術的不斷進步使這些檢測變得更小、更準確、更容易使用。隨著數位醫療系統互聯互通的增強以及檢測能力的不斷提升，即時血脂檢測正成為預防工作的重要組成部分。

目錄

第 1 章。照護現場脂質檢測市場：調查方法和範圍

第 2 章。照護現場脂質檢測市場：執行摘要

  • 市場概述
  • 產品與應用簡介
  • 疾病適應症簡介
  • 最終用途簡介
  • 競爭格局簡介

第3章照護現場脂質檢測市場變數、趨勢與範圍

  • 市場區隔和範圍
  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 波特五力分析
  • PESTLE分析
  • 管道分析

第4章照護現場脂質檢測市場：按產品的估計和趨勢分析

  • 照護現場脂質檢測市場：依產品進行的變化分析
  • 裝置
  • 耗材

第5章照護現場脂質檢測市場：按應用的估計和趨勢分析

  • 照護現場脂質檢測市場：按應用進行的變化分析
  • 高血脂症
  • 高三酸甘油脂血症
  • 丹吉爾病
  • 高脂蛋白血症
  • 遺傳性高膽固醇症
  • 其他

第6章照護現場脂質檢測市場：依疾病適應症的估計與趨勢分析

  • 照護現場脂質檢測市場：依疾病指徵進行的變化分析
  • 脂質和脂蛋白疾病
  • 動脈硬化
  • 肝腎疾病
  • 糖尿病
  • 其他

第7章照護現場脂質檢測市場：依最終用途的估計與趨勢分析

  • 照護現場脂質檢測市場：以最終用途進行的變化分析
  • 醫院
  • 診所
  • 研究和診斷實驗室
  • 其他

第8章照護現場血脂檢測市場：各地區業務分析

  • 區域市場概況
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

第9章 競爭態勢

  • 公司分類
  • 戰略地圖
    • 新產品發布
    • 夥伴關係
    • 獲得
    • 合作
    • 資金籌措
  • 主要企業市場佔有率分析（2024年）
  • 公司熱圖分析
  • 公司簡介
    • Callegari Srl
    • Sinocare Inc.
    • Abbott Laboratories
    • MiCoBio
    • Nova Biomedical
    • VivaChek Biotech（Hangzhou）Co., Ltd.
    • F. Hoffmann-La Roche Ltd.
    • Menarini Group
    • SD Biosensor, Inc.
Product Code: 978-1-68038-750-6

Point of Care Lipid Test Market Summary

The global point of care lipid test market size was estimated at USD 733.3 million in 2024 and is projected to reach USD 1,268.33 million by 2033, growing at a CAGR of 6.05% from 2025 to 2033. Market growth is driven by rising demand for rapid and accessible lipid profiling in both clinical and non-clinical settings, especially for early detection and monitoring of cardiovascular conditions.

Point of care lipid testing offers convenience, reduced turnaround time, and immediate clinical decision-making support, contributing to its adoption across primary care centers, pharmacies, and community health programs.

The increasing prevalence of dyslipidemia and lifestyle-related disorders, combined with growing awareness of cardiovascular risk management, supports the market's momentum. Integration of these tests with digital health platforms and mobile diagnostics is further enabling decentralized screening and preventive care delivery, particularly in underserved and rural regions.

Point of care (POC) lipid testing allows healthcare professionals to measure cholesterol and related lipid levels directly at the patient's location, without sending samples to a lab. These tests use small blood samples, usually taken from a finger prick, and provide quick results through portable devices. This helps doctors make faster decisions about treatment, especially for managing cholesterol problems and reducing heart disease risk.

POC lipid tests are commonly used in regular check-ups, chronic disease management, and emergency care. They are especially helpful in remote areas where lab access is limited. Ongoing improvements in technology are making these tests smaller, more accurate, and easier to use. With better connectivity to digital health systems and more advanced testing features, POC lipid testing is becoming an important part of preventive.

Global Point of Care Lipid Test Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global point of care lipid test market report based on product, application, disease indication, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Instruments
  • Consumables
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Hyperlipidemia
  • Hypertriglyceridemia
  • Tangier Disease
  • Hyperlipoproteinemia
  • Familial Hypercholesterolemia
  • Others
  • Disease Indication Outlook (Revenue, USD Million, 2021 - 2033)
  • Lipid and Lipoprotein Disorders
  • Atherosclerosis
  • Liver and Renal Diseases
  • Diabetes Mellitus
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Clinics
  • Research and Diagnostic Laboratories
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Point of Care Lipid Test Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Product Segment
      • 1.1.1.2. Application Segment
      • 1.1.1.3. Disease Indication segment
      • 1.1.1.4. End Use
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Point of Care Lipid Test Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Product and Application Snapshot
  • 2.3. Disease Indication Snapshot
  • 2.4. End Use Snapshot
  • 2.5. Competitive Landscape Snapshot

Chapter 3. Point of Care Lipid Test Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Porter's Five Forces Analysis
  • 3.5. PESTLE Analysis
  • 3.6. Pipeline Analysis

Chapter 4. Point of Care Lipid Test Market: Product Estimates & Trend Analysis

  • 4.1. Point of Care Lipid Test Market: Product Movement Analysis
  • 4.2. Instruments
    • 4.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3. Consumables
    • 4.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Point of Care Lipid Test Market: Application Estimates & Trend Analysis

  • 5.1. Point of Care Lipid Test Market: Application Movement Analysis
  • 5.2. Hyperlipidemia
    • 5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.3. Hypertriglyceridemia
    • 5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Tangier Disease
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Hyperlipoproteinemia
    • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Familial Hypercholesterolemia
    • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Others
    • 5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Point of Care Lipid Test Market: Indication Outlook Estimates & Trend Analysis

  • 6.1. Point of Care Lipid Test Market: Technology Movement Analysis
  • 6.2. Lipid and Lipoprotein Disorders
    • 6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3. Atherosclerosis
    • 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Liver and Renal Diseases
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Diabetes Mellitus
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Point of Care Lipid Test Market: End Use Estimates & Trend Analysis

  • 7.1. Point of Care Lipid Test Market: End Use Movement Analysis
  • 7.2. Hospitals
    • 7.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3. Clinics
    • 7.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Research and Diagnostic Laboratories
    • 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Others
    • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Point of Care Lipid Test Market: Regional Business Analysis

  • 8.1. Regional Market Snapshot
  • 8.2. North America
    • 8.2.1. North America Point of Care Lipid Test Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
      • 8.2.2.2. Key Country Dynamics
      • 8.2.2.3. Regulatory Framework
      • 8.2.2.4. Reimbursement Scenario
      • 8.2.2.5. Competitive Scenario
    • 8.2.3. Canada
      • 8.2.3.1. Canada Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
      • 8.2.3.2. Key Country Dynamics
      • 8.2.3.3. Regulatory Framework
      • 8.2.3.4. Reimbursement Scenario
      • 8.2.3.5. Competitive Scenario
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
      • 8.2.4.2. Key Country Dynamics
      • 8.2.4.3. Regulatory Framework
      • 8.2.4.4. Reimbursement Scenario
      • 8.2.4.5. Competitive Scenario
  • 8.3. Europe
    • 8.3.1. Europe Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. UK Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
      • 8.3.2.2. Key Country Dynamics
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. Reimbursement Scenario
      • 8.3.2.5. Competitive Scenario
    • 8.3.3. Germany
      • 8.3.3.1. Germany Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
      • 8.3.3.2. Key Country Dynamics
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Reimbursement Scenario
      • 8.3.3.5. Competitive Scenario
    • 8.3.4. Spain
      • 8.3.4.1. Spain Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
      • 8.3.4.2. Key Country Dynamics
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Reimbursement Scenario
      • 8.3.4.5. Competitive Scenario
    • 8.3.5. France
      • 8.3.5.1. France Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
      • 8.3.5.2. Key Country Dynamics
      • 8.3.5.3. Regulatory Framework
      • 8.3.5.4. Reimbursement Scenario
      • 8.3.5.5. Competitive Scenario
    • 8.3.6. Italy
      • 8.3.6.1. Italy Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
      • 8.3.6.2. Key Country Dynamics
      • 8.3.6.3. Regulatory Framework
      • 8.3.6.4. Reimbursement Scenario
      • 8.3.6.5. Competitive Scenario
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
      • 8.3.7.2. Key Country Dynamics
      • 8.3.7.3. Regulatory Framework
      • 8.3.7.4. Reimbursement Scenario
      • 8.3.7.5. Competitive Scenario
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
      • 8.3.8.2. Key Country Dynamics
      • 8.3.8.3. Regulatory Framework
      • 8.3.8.4. Reimbursement Scenario
      • 8.3.8.5. Competitive Scenario
    • 8.3.9. Norway
      • 8.3.9.1. Norway Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
      • 8.3.9.2. Key Country Dynamics
      • 8.3.9.3. Regulatory Framework
      • 8.3.9.4. Reimbursement Scenario
      • 8.3.9.5. Competitive Scenario
  • 8.4. Asia Pacific
    • 8.4.1. Asia-Pacific Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Japan Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
      • 8.4.2.2. Key Country Dynamics
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Reimbursement Scenario
      • 8.4.2.5. Competitive Scenario
    • 8.4.3. China
      • 8.4.3.1. China Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
      • 8.4.3.2. Key Country Dynamics
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Reimbursement Scenario
      • 8.4.3.5. Competitive Scenario
    • 8.4.4. India
      • 8.4.4.1. India Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
      • 8.4.4.2. Key Country Dynamics
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Reimbursement Scenario
      • 8.4.4.5. Competitive Scenario
    • 8.4.5. South Korea
      • 8.4.5.1. South Korea Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
      • 8.4.5.2. Key Country Dynamics
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Reimbursement Scenario
      • 8.4.5.5. Competitive Scenario
    • 8.4.6. Thailand
      • 8.4.6.1. Thailand Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
      • 8.4.6.2. Key Country Dynamics
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Reimbursement Scenario
      • 8.4.6.5. Competitive Scenario
    • 8.4.7. Australia
      • 8.4.7.1. Australia Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
      • 8.4.7.2. Key Country Dynamics
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Reimbursement Scenario
      • 8.4.7.5. Competitive Scenario
  • 8.5. Latin America
    • 8.5.1. Latin America Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
      • 8.5.2.2. Key Country Dynamics
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Reimbursement Scenario
      • 8.5.2.5. Competitive Scenario
    • 8.5.3. Argentina
      • 8.5.3.1. Argentina Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
      • 8.5.3.2. Key Country Dynamics
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Reimbursement Scenario
      • 8.5.3.5. Competitive Scenario
  • 8.6. MEA
    • 8.6.1. MEA Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
      • 8.6.2.2. Key Country Dynamics
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Reimbursement Scenario
      • 8.6.2.5. Competitive Scenario
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Saudi Arabia Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
      • 8.6.3.2. Key Country Dynamics
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Reimbursement Scenario
      • 8.6.3.5. Competitive Scenario
    • 8.6.4. UAE
      • 8.6.4.1. UAE Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
      • 8.6.4.2. Key Country Dynamics
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Reimbursement Scenario
      • 8.6.4.5. Competitive Scenario
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
      • 8.6.5.2. Key Country Dynamics
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Reimbursement Scenario
      • 8.6.5.5. Competitive Scenario

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
    • 9.2.1. New Product Launch
    • 9.2.2. Partnerships
    • 9.2.3. Acquisition
    • 9.2.4. Collaboration
    • 9.2.5. Funding
  • 9.3. Key Company Market Share Analysis, 2024
  • 9.4. Company Heat Map Analysis
  • 9.5. Company Profiles
    • 9.5.1. Callegari Srl
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Financial Performance
      • 9.5.1.3. Product Benchmarking
      • 9.5.1.4. Strategic Initiatives
    • 9.5.2. Sinocare Inc.
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Product Benchmarking
      • 9.5.2.4. Strategic Initiatives
    • 9.5.3. Abbott Laboratories
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Financial Performance
      • 9.5.3.3. Product Benchmarking
      • 9.5.3.4. Strategic Initiatives
    • 9.5.4. MiCoBio
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Financial Performance
      • 9.5.4.3. Product Benchmarking
      • 9.5.4.4. Strategic Initiatives
    • 9.5.5. Nova Biomedical
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Financial Performance
      • 9.5.5.3. Product Benchmarking
      • 9.5.5.4. Strategic Initiatives
    • 9.5.6. VivaChek Biotech (Hangzhou) Co., Ltd.
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Financial Performance
      • 9.5.6.3. Product Benchmarking
      • 9.5.6.4. Strategic Initiatives
    • 9.5.7. F. Hoffmann-La Roche Ltd.
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Financial Performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Strategic Initiatives
    • 9.5.8. Menarini Group
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Financial Performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Strategic Initiatives
    • 9.5.9. SD Biosensor, Inc.
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Financial Performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global Point of Care Lipid Test Market, By Region, 2021 - 2033 (USD Million)
  • Table 4 Global Point of Care Lipid Test Market, By Application, 2021 - 2033 (USD Million)
  • Table 5 Global Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
  • Table 6 Global Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
  • Table 7 Global Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
  • Table 8 North America Point of Care Lipid Test Market, By Country, 2021 - 2033 (USD Million)
  • Table 9 North America Point of Care Lipid Test Market, By Application, 2021 - 2033 (USD Million)
  • Table 10 North America Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
  • Table 11 North America Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
  • Table 12 North America Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
  • Table 13 U.S. Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
  • Table 14 U.S. Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
  • Table 15 U.S Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
  • Table 16 U.S. Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
  • Table 17 Canada Point of Care Lipid Test Market, By Application, 2021 - 2033 (USD Million)
  • Table 18 Canada Point of Care Lipid Test Market, by Product, 2021 - 2033 (USD Million)
  • Table 19 Canada Point of Care Lipid Test Market, by Disease Indication, 2021 - 2033 (USD Million)
  • Table 20 Canada Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
  • Table 21 Mexico Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
  • Table 22 Mexico Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
  • Table 23 Mexico Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
  • Table 24 Mexico Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
  • Table 25 Europe Point of Care Lipid Test Market, by country, 2021 - 2033 (USD Million)
  • Table 26 Europe Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
  • Table 27 Europe Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
  • Table 28 Europe Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
  • Table 29 Europe Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
  • Table 30 UK Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
  • Table 31 UK Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
  • Table 32 UK Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
  • Table 33 UK Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
  • Table 34 Germany Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
  • Table 35 Germany Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
  • Table 36 Germany Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
  • Table 37 Germany Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
  • Table 38 France Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
  • Table 39 France Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
  • Table 40 France Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
  • Table 41 France Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
  • Table 42 Italy Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
  • Table 43 Italy Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
  • Table 44 Italy Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
  • Table 45 Italy Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
  • Table 46 Spain Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
  • Table 47 Spain Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
  • Table 48 Spain Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
  • Table 49 Spain Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
  • Table 50 Sweden Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
  • Table 51 Sweden Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
  • Table 52 Sweden Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
  • Table 53 Sweden Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
  • Table 54 Norway Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
  • Table 55 Norway Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
  • Table 56 Norway Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
  • Table 57 Norway Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
  • Table 58 Denmark Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
  • Table 59 Denmark Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
  • Table 60 Denmark Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
  • Table 61 Denmark Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific Point of Care Lipid Test Market, by country, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
  • Table 66 Asia Pacific Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
  • Table 67 Japan Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
  • Table 68 Japan Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
  • Table 69 Japan Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
  • Table 70 Japan Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
  • Table 71 China Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
  • Table 72 China Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
  • Table 73 China Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
  • Table 74 China Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
  • Table 75 India Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
  • Table 76 India Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
  • Table 77 India Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
  • Table 78 India Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
  • Table 79 Australia Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
  • Table 80 Australia Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
  • Table 81 Australia Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
  • Table 82 Australia Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
  • Table 83 Thailand Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
  • Table 84 Thailand Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
  • Table 85 Thailand Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
  • Table 86 Thailand Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
  • Table 87 South Korea Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
  • Table 88 South Korea Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
  • Table 89 South Korea Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
  • Table 90 South Korea Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
  • Table 91 Latin America Point of Care Lipid Test Market, by country, 2021 - 2033 (USD Million)
  • Table 92 Latin America Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
  • Table 93 Latin America Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
  • Table 94 Latin America Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
  • Table 95 Latin America Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
  • Table 96 Brazil Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
  • Table 97 Brazil Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
  • Table 98 Brazil Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
  • Table 99 Brazil Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
  • Table 100 Argentina Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
  • Table 101 Argentina Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
  • Table 102 Argentina Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
  • Table 103 Argentina Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
  • Table 104 MEA Point of Care Lipid Test Market, by country, 2021 - 2033 (USD Million)
  • Table 105 MEA Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
  • Table 106 MEA Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
  • Table 107 MEA Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
  • Table 108 MEA Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
  • Table 109 South Africa Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
  • Table 110 South Africa Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
  • Table 111 South Africa Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
  • Table 112 South Africa Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
  • Table 116 Saudi Arabia Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
  • Table 117 UAE Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
  • Table 118 UAE Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
  • Table 119 UAE Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
  • Table 120 UAE Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
  • Table 121 Kuwait Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD)
  • Table 122 Kuwait Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
  • Table 123 Kuwait Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
  • Table 124 Kuwait Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market summary
  • Fig. 4 Market segmentation & scope
  • Fig. 5 Market size and growth prospects
  • Fig. 6 Global Point of Care Lipid Test market- Key market driver analysis
  • Fig. 7 Global Point of Care Lipid Test market - Key market restraint analysis
  • Fig. 8 Penetration & growth prospect mapping
  • Fig. 9 Global Point of Care Lipid Test market - Porter's analysis
  • Fig. 10 Global Point of Care Lipid Test market - PESTEL analysis
  • Fig. 11 Global Point of Care Lipid Test market product outlook key takeaways
  • Fig. 12 Global Point of Care Lipid Test market: Product movement analysis
  • Fig. 13 Instruments market estimates, 2021 - 2033 (USD Million)
  • Fig. 14 Consumables market estimates, 2021 - 2033 (USD Million)
  • Fig. 15 Global Point of Care Lipid Test market Application outlook key takeaways
  • Fig. 16 Global Point of Care Lipid Test market: Application movement analysis
  • Fig. 17 Hyperlipidemia market estimates, 2021 - 2033 (USD Million)
  • Fig. 18 Hypertriglyceridemia market estimates, 2021 - 2033 (USD Million)
  • Fig. 19 Tangier Disease market estimates, 2021 - 2033 (USD Million)
  • Fig. 20 Hyperlipoproteinemia market estimates, 2021 - 2033 (USD Million)
  • Fig. 21 Familial Hypercholesterolemia market estimates, 2021 - 2033 (USD Million)
  • Fig. 22 Global Point of Care Lipid Test market Disease Indication outlook key takeaways
  • Fig. 23 Global Point of Care Lipid Test market: Disease Indication movement analysis
  • Fig. 24 Lipid and Lipoprotein Disorders market estimates, 2021 - 2033 (USD Million)
  • Fig. 25 Atherosclerosis market estimates, 2021 - 2033 (USD Million)
  • Fig. 26 Liver and Renal Diseases market estimates, 2021 - 2033 (USD Million)
  • Fig. 27 Diabetes Mellitus market estimates, 2021 - 2033 (USD Million)
  • Fig. 28 Global Point of Care Lipid Test market End Use outlook key takeaways
  • Fig. 29 Global Point of Care Lipid Test market: End Use movement analysis
  • Fig. 30 Hospitals market estimates, 2021 - 2033 (USD Million)
  • Fig. 31 Clinics market estimates, 2021 - 2033 (USD Million)
  • Fig. 32 Research and Diagnostic Laboratories market estimates, 2021 - 2033 (USD Million)
  • Fig. 33 Regional marketplace: Key takeaways
  • Fig. 34 Global Point of Care Lipid Test market: Regional movement analysis
  • Fig. 35 North America Point of Care Lipid Test market, 2021 - 2033 (USD Million)
  • Fig. 36 U.S. Point of Care Lipid Test market, 2021 - 2033 (USD Million)
  • Fig. 37 Canada Point of Care Lipid Test market, 2021 - 2033 (USD Million)
  • Fig. 38 Mexico Point of Care Lipid Test market, 2021 - 2033 (USD Million)
  • Fig. 39 Europe Point of Care Lipid Test market, 2021 - 2033 (USD Million)
  • Fig. 40 UK Point of Care Lipid Test market, 2021 - 2033 (USD Million)
  • Fig. 41 Germany Point of Care Lipid Test market, 2021 - 2033 (USD Million)
  • Fig. 42 France Point of Care Lipid Test market, 2021 - 2033 (USD Million)
  • Fig. 43 Spain Point of Care Lipid Test market, 2021 - 2033 (USD Million)
  • Fig. 44 Italy Point of Care Lipid Test market, 2021 - 2033 (USD Million)
  • Fig. 45 Denmark Point of Care Lipid Test market, 2021 - 2033 (USD Million)
  • Fig. 46 Sweden Point of Care Lipid Test market, 2021 - 2033 (USD Million)
  • Fig. 47 Norway Point of Care Lipid Test market, 2021 - 2033 (USD Million)
  • Fig. 48 Asia Pacific Point of Care Lipid Test market, 2021 - 2033 (USD Million)
  • Fig. 49 Japan Point of Care Lipid Test market, 2021 - 2033 (USD Million)
  • Fig. 50 China Point of Care Lipid Test market, 2021 - 2033 (USD Million)
  • Fig. 51 India Point of Care Lipid Test market, 2021 - 2033 (USD Million)
  • Fig. 52 South Korea Point of Care Lipid Test market, 2021 - 2033 (USD Million)
  • Fig. 53 Australia Point of Care Lipid Test market, 2021 - 2033 (USD Million)
  • Fig. 54 Thailand Point of Care Lipid Test market, 2021 - 2033 (USD Million)
  • Fig. 55 Latin America Point of Care Lipid Test market, 2021 - 2033 (USD Million)
  • Fig. 56 Brazil Point of Care Lipid Test market, 2021 - 2033 (USD Million)
  • Fig. 57 Argentina Point of Care Lipid Test market, 2021 - 2033 (USD Million)
  • Fig. 58 MEA Point of Care Lipid Test market, 2021 - 2033 (USD Million)
  • Fig. 59 South Africa Point of Care Lipid Test market, 2021 - 2033 (USD Million)
  • Fig. 60 Saudi Arabia Point of Care Lipid Test market, 2021 - 2033 (USD Million)
  • Fig. 61 UAE Point of Care Lipid Test market, 2021 - 2033 (USD Million)
  • Fig. 62 Kuwait Point of Care Lipid Test market, 2021 - 2033 (USD Million)
  • Fig. 63 Strategy framework